- Home
- KLTR vs ORMP Comparison
KLTR vs ORMP Comparison
Compare KLTR & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KLTR | ORMP |
|---|---|---|
| Founded | 2006 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 199.8M | 197.6M |
| IPO Year | 2021 | 2010 |
Fundamental Metrics
Financial Performance| Metric | KLTR | ORMP |
|---|---|---|
| Price | $1.50 | $4.06 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $3.50 | N/A |
| AVG Volume (30 Days) | ★ 183.1K | 111.9K |
| Earning Date | 11-09-2026 | 11-12-2026 |
| Dividend Yield | N/A | ★ 6.08% |
| EPS Growth | 61.90 | ★ 412.50 |
| EPS | N/A | ★ 2.76 |
| Revenue | ★ $180,854,000.00 | $2,000,000.00 |
| Revenue This Year | $1.74 | N/A |
| Revenue Next Year | $4.18 | N/A |
| P/E Ratio | ★ N/A | $1.49 |
| Revenue Growth | 1.20 | ★ 49.25 |
| 52 Week Low | $1.06 | $2.09 |
| 52 Week High | $2.05 | $5.47 |
Technical Indicators
Market Signals| Indicator | KLTR | ORMP |
|---|---|---|
| Relative Strength Index (RSI) | 59.86 | 37.07 |
| Support Level | $1.46 | $3.90 |
| Resistance Level | $1.54 | $4.22 |
| Average True Range (ATR) | 0.07 | 0.14 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 81.40 | 43.00 |
Price Performance
Historical ComparisonAbout KLTR Kaltura Inc.
Kaltura Inc provides live and on-demand video SaaS solutions to thousands of organizations around the world, engaging hundreds of millions of viewers at home, at work, and at school. It also offers specialized industry solutions, including Learning Management System Video, Lecture Capture, and Virtual Classroom for educational institutions, as well as a TV Solution for media and telecom companies. It operates in two reporting segments which are Enterprise, Education, and Technology, and Media and Telecom. The majority of the revenue is derived from Enterprise, Education & Technology. The majority of the revenue is earned from the United States.
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.